New drug labels for kidney disease patients -- what do they mean? - EurekAlert (press release) Print
EurekAlert (press release)
In addition, if a dialysis patient's hemoglobin level approaches or exceeds 11 g/dL (10 g/dL for a CKD patient not on dialysis), clinicians should reduce or hold the dose of ESA. (The drug label previously recommended that ESAs be dosed to achieve and

...